<li>adenosine<p>carvedilol, adenosine. Mechanism: pharmacodynamic synergism. Minor/Significance Unknown. Bradycardia.</p></li><li>agrimony<p>agrimony increases effects of carvedilol by pharmacodynamic synergism. Minor/Significance Unknown.</p></li><li>brimonidine<p>brimonidine increases effects of carvedilol by pharmacodynamic synergism. Minor/Significance Unknown.</p></li><li>cevimeline<p>cevimeline increases effects of carvedilol by unspecified interaction mechanism. Minor/Significance Unknown.</p></li><li>ciprofloxacin<p>ciprofloxacin increases levels of carvedilol by decreasing metabolism. Minor/Significance Unknown. May also rarely decrease beta blocker levels.</p></li><li>cocaine<p>carvedilol increases effects of cocaine by pharmacodynamic synergism. Minor/Significance Unknown. Risk of angina.</p></li><li>cornsilk<p>cornsilk increases effects of carvedilol by pharmacodynamic synergism. Minor/Significance Unknown.</p></li><li>dihydroergotamine<p>dihydroergotamine, carvedilol. Mechanism: pharmacodynamic synergism. Minor/Significance Unknown. Additive vasospasm.</p></li><li>dihydroergotamine intranasal<p>dihydroergotamine intranasal, carvedilol. Mechanism: pharmacodynamic synergism. Minor/Significance Unknown. Additive vasospasm.</p></li><li>dipyridamole<p>dipyridamole, carvedilol. Mechanism: pharmacodynamic synergism. Minor/Significance Unknown. Risk of bradycardia.</p></li><li>duloxetine<p>duloxetine will increase the level or effect of carvedilol by  affecting hepatic enzyme CYP2D6 metabolism. Minor/Significance Unknown.</p></li><li>escitalopram<p>escitalopram increases levels of carvedilol by decreasing metabolism. Minor/Significance Unknown.</p></li><li>fenoldopam<p>fenoldopam increases effects of carvedilol by pharmacodynamic synergism. Minor/Significance Unknown. Additive hypotensive effects.</p></li><li>forskolin<p>forskolin increases effects of carvedilol by pharmacodynamic synergism. Minor/Significance Unknown.</p></li><li>imaging agents (gadolinium)<p>carvedilol, imaging agents (gadolinium). Mechanism: unknown. Minor/Significance Unknown. Increased risk of anaphylaxis from contrast media.</p></li><li>levobetaxolol<p>levobetaxolol increases effects of carvedilol by pharmacodynamic synergism. Minor/Significance Unknown.</p></li><li>lofexidine<p>lofexidine increases effects of carvedilol by pharmacodynamic synergism. Minor/Significance Unknown.</p></li><li>maitake<p>maitake increases effects of carvedilol by pharmacodynamic synergism. Minor/Significance Unknown.</p></li><li>melatonin<p>melatonin decreases toxicity of carvedilol by pharmacodynamic antagonism. Minor/Significance Unknown. Melatonin may correct beta blocker induced sleep disturbances.</p></li><li>metipranolol ophthalmic<p>metipranolol ophthalmic increases effects of carvedilol by pharmacodynamic synergism. Minor/Significance Unknown.</p></li><li>neostigmine<p>carvedilol, neostigmine.
Either increases effects of the other by pharmacodynamic synergism. Minor/Significance Unknown. Additive bradycardia.</p></li><li>noni juice<p>carvedilol and noni juice both increase  serum potassium. Minor/Significance Unknown.</p></li><li>norfloxacin<p>norfloxacin increases levels of carvedilol by decreasing elimination. Minor/Significance Unknown. May also rarely decrease beta blocker levels.</p></li><li>octacosanol<p>octacosanol increases effects of carvedilol by pharmacodynamic synergism. Minor/Significance Unknown.</p></li><li>omeprazole<p>omeprazole will increase the level or effect of carvedilol by  affecting hepatic enzyme CYP2C9/10 metabolism. Minor/Significance Unknown.</p></li><li>physostigmine<p>carvedilol, physostigmine.
Either increases effects of the other by pharmacodynamic synergism. Minor/Significance Unknown. Additive bradycardia.</p></li><li>pilocarpine<p>pilocarpine increases effects of carvedilol by pharmacodynamic synergism. Minor/Significance Unknown.</p></li><li>reishi<p>reishi increases effects of carvedilol by pharmacodynamic synergism. Minor/Significance Unknown.</p></li><li>shepherd's purse<p>shepherd's purse, carvedilol. Other (see comment). Minor/Significance Unknown. 
Comment: Theoretically, shepherd's purse may interfere with BP control.</p></li><li>sildenafil<p>sildenafil increases effects of carvedilol by pharmacodynamic synergism. Minor/Significance Unknown. Risk of hypotension.</p></li><li>tizanidine<p>tizanidine increases effects of carvedilol by pharmacodynamic synergism. Minor/Significance Unknown. Risk of hypotension.</p></li><li>treprostinil<p>treprostinil increases effects of carvedilol by pharmacodynamic synergism. Minor/Significance Unknown.</p></li><li>vardenafil<p>vardenafil increases effects of carvedilol by pharmacodynamic synergism. Minor/Significance Unknown. Risk of hypotension.</p></li><li>yohimbe<p>carvedilol decreases toxicity of yohimbe by pharmacodynamic antagonism. Minor/Significance Unknown.</p></li>